IMM CHART / SP, page-182

Disappoints my arrss here.
These so called analysts are just taking advantage of timing of this one. As they know this AIPAC ph3 is not going anywhere any sooner. Even there might be a big partnership deal jump out of the bush, they might still be the ones to know it before retails as doctors/researchers/practictioners in pharma industry talk a lot. So during this time when the company is preparing the new study or talks to FDA, instos just play with us and squizz profit out of the market.

In terms of the 'analyst report', those are no more than a 'copy'/'paste' style article to me. They never really tell the truth or give out the good analysis for free, that's for sure. Instead, putting a 'disappoints' in the title, that is just so convinent to drive the market sentiment.